Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer
Abstract Purpose Hormone receptor-positive breast cancer is characterized by the expression of estrogen receptor (ER) or progesterone receptor (PR), it is generally associated with less aggressive clinical features and more favorable prognostic outcomes, primarily due to the effectiveness of endocri...
Saved in:
| Main Authors: | Zhengjia Lu, Jiao Yang, Yang Feng, Jia Ming |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14451-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2023-09-01) -
Relationship between p53 protein and ER, PR status in breast cancer tissue
by: Fang Zhang
Published: (2025-01-01) -
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer
by: Zhengjia Lu, et al.
Published: (2025-06-01) -
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone
by: James N. Ingle, et al.
Published: (2025-03-01) -
Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01)